Cancer Research Institute International Symposia Series
The Institute's International Symposia Series, established in 1991,
is considered by many as "the Davos of cancer immunology,"
where the world's scientific leaders in immunology and tumor immunology
gather together to shape the future course of cancer research.
annual meetings focus attention on progress in cancer vaccines and
antibody-based therapies, the two central approaches of cancer immunology.
Over the course of three days, researchers involved in the discovery
and development of immune-based therapies for cancer share information,
stimulating new ideas and collaborations that could benefit the
development of experimental cancer immunotherapies.
the CRI Symposium webpage